Not applicableUnknownNCT06115213What this trial is testingThe North Kynouria ProjectWho this might be right forCardiovascular DiseasesHeart DiseasesCerebrovascular Disease+7 more University Hospital, Ioannina 7,000
Not applicableEnded earlyNCT05834673What this trial is testingVICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)Who this might be right forAtherosclerotic Cardiovascular Disease (ASCVD)Coronary Heart Disease (CHD)Cerebrovascular Disease+1 more Monash University 6
Large-scale testing (Phase 3)Study completedNCT01516541What this trial is testingDalcetrapib in Patients With Stable Coronary Heart Disease, With Coronary Heart Disease Risk Equivalents or at Elevated Risk for Cardiovascular DiseaseWho this might be right forCardiovascular Disease, Coronary Heart Disease, Dyslipidemia, Peripheral Arterial Disease (PAD) Hoffmann-La Roche 2,220
Not applicableEnrolling By InvitationNCT04929457What this trial is testingEvaluation of a Digiphysical Screening Method to Identify and Diagnose Familial HypercholesterolemiaWho this might be right forFamilial HypercholesterolemiaHypercholesterolemia Karolinska Institutet 30,000
Not applicableStudy completedNCT01768403What this trial is testingCentralised Pan-Algerian Survey on the Undertreatment of HypercholesterolemiaWho this might be right forHypercholesterolemiaCardiovascular DiseaseHypertension+3 more AstraZeneca 1,236
Post-approval studies (Phase 4)Study completedNCT05192941What this trial is testingStudy of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With HypercholesterolemiaWho this might be right forHypercholesterolemia Novartis Pharmaceuticals 1,770
Not applicableStudy completedNCT01642355What this trial is testingPrevention Trial to Achieve Cardiovascular TargetsWho this might be right forCoronary Artery DiseasePeripheral Arterial DiseaseHyperlipidemia+4 more NYU Langone Health 400
Not applicableStudy completedNCT05974345What this trial is testingIn Silico Study Assessing the Impact of Inclisiran on Major Adverse Cardiovascular Events in Patients With Established Cardiovascular DiseaseWho this might be right forAtherosclerotic Cardiovascular Disease Novartis Pharmaceuticals 204,691
Not applicableStudy completedNCT02341664What this trial is testingPatient and Provider Assessment of Lipid Management RegistryWho this might be right forHyperlipidemiaHypercholesterolemiaCardiovascular Disease+14 more Duke University 7,658
Not applicableWithdrawnNCT01064934What this trial is testingRandomized Controlled Trial of Lipid Apheresis in Patients With Elevated Lipoprotein(a)Who this might be right forHyperlipoproteinemia(a)Progressive Cardiovascular Disease Charite University, Berlin, Germany
Large-scale testing (Phase 3)Study completedNCT01598948What this trial is testingEffect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular ApheresisWho this might be right forAtherosclerosisLDL-hypercholesterolemia Ludwig-Maximilians - University of Munich 17
Not applicableLooking for participantsNCT07334834What this trial is testingImplementation of an Algorithm- and Multi-professional Team-supported Strategy to Improve Lipid Management of Patients With Atherosclerotic Cardiovascular DiseaseWho this might be right forHyperlipidemia Colorado Prevention Center 100
Not applicableNot Yet RecruitingNCT06675994What this trial is testingIn Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 EnzymeWho this might be right forHealthyHypercholesterolemiaHypertension+6 more LifeBridge Health 80